113 related articles for article (PubMed ID: 14725901)
21. Stat5a is essential for the proliferation and survival of murine mast cells.
Ikeda K; Nakajima H; Suzuki K; Watanabe N; Kagami S; Iwamoto I
Int Arch Allergy Immunol; 2005; 137 Suppl 1():45-50. PubMed ID: 15947484
[TBL] [Abstract][Full Text] [Related]
22. Role of STAT6 and mast cells in IL-4- and IL-13-induced alterations in murine intestinal epithelial cell function.
Madden KB; Whitman L; Sullivan C; Gause WC; Urban JF; Katona IM; Finkelman FD; Shea-Donohue T
J Immunol; 2002 Oct; 169(8):4417-22. PubMed ID: 12370375
[TBL] [Abstract][Full Text] [Related]
23. FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing upregulation of c-kit expression in cells of the mast cell line MC/9.
Ito F; Toyota N; Sakai H; Takahashi H; Iizuka H
Arch Dermatol Res; 1999 May; 291(5):275-83. PubMed ID: 10367710
[TBL] [Abstract][Full Text] [Related]
24. Stat5: an essential regulator of mast cell biology.
Shelburne CP; McCoy ME; Piekorz R; Sexl VV; Gillespie SR; Bailey DP; Gharse A; Mirmonsef P; Mann MN; Kashyap M; Wright HV; Chong HJ; Bouton LA; Ramirez CD; Lantz CS; Ryan JJ
Mol Immunol; 2002 Sep; 38(16-18):1187-91. PubMed ID: 12217382
[TBL] [Abstract][Full Text] [Related]
25. Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P.
Karimi K; Redegeld FA; Blom R; Nijkamp FP
Exp Hematol; 2000 Jun; 28(6):626-34. PubMed ID: 10880748
[TBL] [Abstract][Full Text] [Related]
26. IL-4 modulates the histamine content of mast cells in a mast cell/fibroblast co-culture through a Stat6 signaling pathway in fibroblasts.
Nabeshima Y; Hiragun T; Morita E; Mihara S; Kameyoshi Y; Hide M
FEBS Lett; 2005 Dec; 579(29):6653-8. PubMed ID: 16298365
[TBL] [Abstract][Full Text] [Related]
27. STAT6 is required for the regulation of IL-4-induced cytoskeletal events in B cells.
Davey EJ; Greicius G; Thyberg J; Severinson E
Int Immunol; 2000 Jul; 12(7):995-1003. PubMed ID: 10882411
[TBL] [Abstract][Full Text] [Related]
28. Expression of a constitutively active Stat6 in vivo alters lymphocyte homeostasis with distinct effects in T and B cells.
Bruns HA; Schindler U; Kaplan MH
J Immunol; 2003 Apr; 170(7):3478-87. PubMed ID: 12646608
[TBL] [Abstract][Full Text] [Related]
29. JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis.
Yan J; Zhang Z; Yang J; Mitch WE; Wang Y
J Am Soc Nephrol; 2015 Dec; 26(12):3060-71. PubMed ID: 26032813
[TBL] [Abstract][Full Text] [Related]
30. The role of STAT6 in mast cell IL-4 production.
Sherman MA
Immunol Rev; 2001 Feb; 179():48-56. PubMed ID: 11292026
[TBL] [Abstract][Full Text] [Related]
31. Stat6 activation is essential for interleukin-4 induction of P-selectin transcription in human umbilical vein endothelial cells.
Khew-Goodall Y; Wadham C; Stein BN; Gamble JR; Vadas MA
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1421-9. PubMed ID: 10364072
[TBL] [Abstract][Full Text] [Related]
32. Ceramide and sphingosine rapidly induce apoptosis of murine mast cells supported by interleukin-3 and stem cell factor.
Itakura A; Tanaka A; Aioi A; Tonogaito H; Matsuda H
Exp Hematol; 2002 Mar; 30(3):272-8. PubMed ID: 11882365
[TBL] [Abstract][Full Text] [Related]
33. IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells.
Suzuki K; Nakajima H; Ikeda K; Maezawa Y; Suto A; Takatori H; Saito Y; Iwamoto I
J Exp Med; 2003 Dec; 198(11):1717-27. PubMed ID: 14638848
[TBL] [Abstract][Full Text] [Related]
34. IL-4 induces the proteolytic processing of mast cell STAT6.
Sherman MA; Powell DR; Brown MA
J Immunol; 2002 Oct; 169(7):3811-8. PubMed ID: 12244176
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4.
Vella A; Teague TK; Ihle J; Kappler J; Marrack P
J Exp Med; 1997 Jul; 186(2):325-30. PubMed ID: 9221762
[TBL] [Abstract][Full Text] [Related]
36. STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells.
Gooch JL; Christy B; Yee D
Neoplasia; 2002; 4(4):324-31. PubMed ID: 12082548
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor γ agonist suppresses mast cell maturation and induces apoptosis.
Zhang Y; Li X; Fang S; Zhu Z; Yao M; Ying L; Zhu L; Ma Z; Wang W
Mol Med Rep; 2017 Aug; 16(2):1793-1800. PubMed ID: 28656266
[TBL] [Abstract][Full Text] [Related]
38. Stem cell factor and interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro.
Karimi K; Redegeld FA; Heijdra B; Nijkamp FP
Exp Hematol; 1999 Apr; 27(4):654-62. PubMed ID: 10210323
[TBL] [Abstract][Full Text] [Related]
39. Stem cell factor activates STAT-5 DNA binding in IL-3-derived bone marrow mast cells.
Ryan JJ; Huang H; McReynolds LJ; Shelburne C; Hu-Li J; Huff TF; Paul WE
Exp Hematol; 1997 Apr; 25(4):357-62. PubMed ID: 9131012
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-4 and -13 induce upregulation of the murine macrophage 12/15-lipoxygenase activity: evidence for the involvement of transcription factor STAT6.
Heydeck D; Thomas L; Schnurr K; Trebus F; Thierfelder WE; Ihle JN; Kühn H
Blood; 1998 Oct; 92(7):2503-10. PubMed ID: 9746791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
